• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国年轻男性的前列腺特异性抗原筛查。

Prostate-specific antigen screening among young men in the United States.

作者信息

Scales Charles D, Antonelli Jodi, Curtis Lesley H, Schulman Kevin A, Moul Judd W

机构信息

Duke Prostate Center, Division of Urology, Department of Surgery, Duke University School of Medicine, Durham, North Carolina 27710, USA.

出版信息

Cancer. 2008 Sep 15;113(6):1315-23. doi: 10.1002/cncr.23667.

DOI:10.1002/cncr.23667
PMID:18696715
Abstract

BACKGROUND

Disagreement exists on the use of prostate-specific antigen (PSA) tests for cancer-risk stratification in young men in the United States. Little is known about the use of PSA testing in these men. To understand policy implications of risk stratification, the authors sought to characterize PSA use among young men.

METHODS

The authors used the 2002 Behavioral Risk Factor Surveillance System to study prostate-cancer screening in a representative sample of men aged 40 years and older (n = 58,511). The primary outcome was self-report of a PSA test in the previous year.

RESULTS

Among men aged 40 to 49 years, 22.5% (95% confidence interval [CI], 21.5-23.5) reported having had a PSA test in the previous year, compared with 53.7% (95% CI, 52.8-54.7; P < .001) of men aged >or=50 years. When sociodemographic characteristics were statistically controlled, young, black, non-Hispanic men were more likely than young, white, non-Hispanic men to report having had a PSA test in the previous year (odds ratio [OR], 2.42; 95% CI, 1.95-3.01; P < .001). In young men, annual household income >or=USD 35,000 (OR, 1.50; 95% CI, 1.26-1.78; P < .001) and an ongoing relationship with a physician (OR, 2.52; 95% CI, 2.06-3.07; P < .001) were associated with PSA testing.

CONCLUSIONS

One-fifth of young men reported having had a PSA test within the previous year. Young, black, non-Hispanic men are more likely than young, white, non-Hispanic men to report having had a PSA test, although screening in this high-risk group remains suboptimal.

摘要

背景

在美国,对于使用前列腺特异性抗原(PSA)检测对年轻男性进行癌症风险分层存在分歧。对于这些男性使用PSA检测的情况知之甚少。为了解风险分层的政策影响,作者试图描述年轻男性中PSA检测的使用情况。

方法

作者使用2002年行为危险因素监测系统,对40岁及以上男性的代表性样本(n = 58,511)进行前列腺癌筛查研究。主要结果是前一年进行PSA检测的自我报告。

结果

在40至49岁的男性中,22.5%(95%置信区间[CI],21.5 - 23.5)报告前一年进行了PSA检测,而50岁及以上男性的这一比例为53.7%(95% CI,52.8 - 54.7;P <.001)。在对社会人口统计学特征进行统计学控制后,年轻的非西班牙裔黑人男性比年轻的非西班牙裔白人男性更有可能报告前一年进行了PSA检测(优势比[OR],2.42;95% CI,1.95 - 3.01;P <.001)。在年轻男性中,家庭年收入≥35,000美元(OR,1.50;95% CI,1.26 - 1.78;P <.001)以及与医生保持持续关系(OR,2.52;95% CI,2.06 - 3.07;P <.001)与PSA检测相关。

结论

五分之一 的年轻男性报告前一年进行了PSA检测。年轻的非西班牙裔黑人男性比年轻的非西班牙裔白人男性更有可能报告进行了PSA检测,尽管该高危人群的筛查仍不理想。

相似文献

1
Prostate-specific antigen screening among young men in the United States.美国年轻男性的前列腺特异性抗原筛查。
Cancer. 2008 Sep 15;113(6):1315-23. doi: 10.1002/cncr.23667.
2
Access to Prostate-Specific Antigen Testing and Mortality Among Men With Prostate Cancer.前列腺特异性抗原检测的应用与前列腺癌患者的死亡率。
JAMA Netw Open. 2024 Jun 3;7(6):e2414582. doi: 10.1001/jamanetworkopen.2024.14582.
3
The impact of sociodemographic factors and PSA screening among low-income Black and White men: data from the Southern Community Cohort Study.社会人口因素和 PSA 筛查对低收入黑人和白人男性的影响:来自南方社区队列研究的数据。
Prostate Cancer Prostatic Dis. 2017 Dec;20(4):424-429. doi: 10.1038/pcan.2017.32. Epub 2017 Jul 11.
4
Use of the prostate-specific antigen test among U.S. men: findings from the 2005 National Health Interview Survey.美国男性中前列腺特异性抗原检测的使用情况:2005年全国健康访谈调查结果
Cancer Epidemiol Biomarkers Prev. 2008 Mar;17(3):636-44. doi: 10.1158/1055-9965.EPI-07-2709.
5
Total, free, and percent free prostate-specific antigen levels among U.S. men, 2001-04.2001 - 2004年美国男性的总前列腺特异性抗原水平、游离前列腺特异性抗原水平及游离前列腺特异性抗原百分比
Adv Data. 2006 Dec 4(379):1-12.
6
Association of healthcare barriers with prostate-specific antigen screening among African-American and Afro-Caribbean men.医疗保健障碍与非裔美国人和 Afro-Caribbean 男性的前列腺特异性抗原筛查的关联。
Urology. 2012 Sep;80(3):556-63. doi: 10.1016/j.urology.2012.02.085. Epub 2012 Jul 11.
7
Obesity and prostate cancer screening among African-American and Caucasian men.非裔美国男性和白人男性中的肥胖与前列腺癌筛查
Prostate. 2006 Sep 15;66(13):1371-80. doi: 10.1002/pros.20377.
8
Screening men for prostate and colorectal cancer in the United States: does practice reflect the evidence?在美国对男性进行前列腺癌和结直肠癌筛查:实际做法是否符合证据?
JAMA. 2003 Mar 19;289(11):1414-20. doi: 10.1001/jama.289.11.1414.
9
Predictors of repeated PSA testing among black and white men from the Maryland Cancer Survey, 2006.2006 年马里兰州癌症调查中黑人和白人男性重复进行 PSA 检测的预测因素。
Prev Chronic Dis. 2011 Sep;8(5):A114. Epub 2011 Aug 15.
10
Impact of Prostate-Specific Antigen Screening Pattern on Prostate Cancer Mortality Among Non-Hispanic Black and Non-Hispanic White Men: A Large, Urban Health System Cohort Analysis.前列腺特异性抗原筛查模式对非裔美国男性和非裔美国白人男性前列腺癌死亡率的影响:一项大型城市卫生系统队列分析。
J Urol. 2024 Oct;212(4):560-570. doi: 10.1097/JU.0000000000004118. Epub 2024 Jul 30.

引用本文的文献

1
Prostate-specific antigen testing in inner London general practices: are those at higher risk most likely to get tested?伦敦市中心普通诊所的前列腺特异性抗原检测:风险较高的人群是否最有可能接受检测?
BMJ Open. 2016 Jul 12;6(7):e011356. doi: 10.1136/bmjopen-2016-011356.
2
Experiences of Uncertainty in Men With an Elevated PSA.前列腺特异性抗原(PSA)升高男性的不确定性经历
Am J Mens Health. 2017 Jan;11(1):24-34. doi: 10.1177/1557988315584376. Epub 2016 Jun 23.
3
Predictors of repeated PSA testing among black and white men from the Maryland Cancer Survey, 2006.
2006 年马里兰州癌症调查中黑人和白人男性重复进行 PSA 检测的预测因素。
Prev Chronic Dis. 2011 Sep;8(5):A114. Epub 2011 Aug 15.
4
Disparities at presentation, diagnosis, treatment, and survival in African American men, affected by prostate cancer.非裔美国男性前列腺癌患者在就诊、诊断、治疗和生存方面存在差异。
Prostate. 2011 Jun 15;71(9):985-97. doi: 10.1002/pros.21314. Epub 2010 Dec 28.
5
Racial/ethnic differences in predictors of PSA screening in a tri-ethnic population.三族裔人群中前列腺特异性抗原(PSA)筛查预测因素的种族/族裔差异。
Cent Eur J Public Health. 2011 Mar;19(1):30-4. doi: 10.21101/cejph.a3622.
6
Interactions among genes, tumor biology and the environment in cancer health disparities: examining the evidence on a national and global scale.癌症健康差异中基因、肿瘤生物学和环境之间的相互作用:在国家和全球范围内检验证据。
Carcinogenesis. 2011 Aug;32(8):1107-21. doi: 10.1093/carcin/bgr066. Epub 2011 Apr 3.
7
Use of the prostate-specific antigen test among men aged 75 years or older in the United States: 2006 Behavioral Risk Factor Surveillance System.美国 75 岁及以上男性中前列腺特异性抗原检测的使用情况:2006 年行为风险因素监测系统。
Prev Chronic Dis. 2010 Jul;7(4):A84. Epub 2010 Jun 15.
8
Contemporary risk profile of prostate cancer in the United States.美国前列腺癌的当代风险概况。
J Natl Cancer Inst. 2009 Sep 16;101(18):1280-3. doi: 10.1093/jnci/djp262. Epub 2009 Aug 27.